RAFFA WEALTH MANAGEMENT, LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.2K | Sell |
674
-60
| -8% | -$1.57K | ﹤0.01% | 329 |
|
|
2026
Q1 | $20.6K | Buy |
734
+192
| +35% | +$5.11K | ﹤0.01% | 265 |
|
|
2025
Q4 | $13.5K | Hold |
542
| – | – | ﹤0.01% | 321 |
|
|
2025
Q3 | $13.8K | Buy |
542
+150
| +38% | +$3.7K | ﹤0.01% | 308 |
|
|
2025
Q2 | $9.5K | Sell |
392
-4,008
| -91% | -$93.5K | ﹤0.01% | 387 |
|
|
2025
Q1 | $111K | Sell |
4,400
-66
| -1% | -$1.73K | 0.03% | 106 |
|
|
2024
Q4 | $118K | Sell |
4,466
-45
| -1% | -$1.22K | 0.03% | 103 |
|
|
2024
Q3 | $131K | Hold |
4,511
| – | – | 0.03% | 96 |
|
|
2024
Q2 | $126K | Buy |
4,511
+1,740
| +63% | +$47.9K | 0.04% | 122 |
|
|
2024
Q1 | $76.9K | Hold |
2,771
| – | – | 0.02% | 165 |
|
|
2023
Q4 | $79.8K | Hold |
2,771
| – | – | 0.02% | 109 |
|
|
2023
Q3 | $91.9K | Buy |
2,771
+27
| +1% | +$955 | 0.03% | 97 |
|
|
2023
Q2 | $101K | Sell |
2,744
-978
| -26% | -$38.1K | 0.03% | 93 |
|
|
2023
Q1 | $152K | Buy |
3,722
+2,184
| +142% | +$94.3K | 0.06% | 76 |
|
|
2022
Q4 | $78.8K | Hold |
1,538
| – | – | 0.03% | 105 |
|
|
2022
Q3 | $67.3K | Sell |
1,538
-507
| -25% | -$24.6K | 0.03% | 114 |
|
|
2022
Q2 | $107K | Buy |
2,045
+507
| +33% | +$25.8K | 0.05% | 85 |
|
|
2022
Q1 | $79.6K | Hold |
1,538
| – | – | 0.03% | 109 |
|
|
2021
Q4 | $90.8K | Sell |
1,538
-125
| -8% | -$6.19K | 0.03% | 102 |
|
|
2021
Q3 | $71.5K | Sell |
1,663
-9
| -0.5% | -$399 | 0.02% | 95 |
|
|
2021
Q2 | $65.5K | Hold |
1,672
| – | – | 0.02% | 105 |
|
|
2021
Q1 | $60.6K | Buy |
1,672
+111
| +7% | +$3.94K | 0.02% | 123 |
|
|
2020
Q4 | $57.5K | Sell |
1,561
-84
| -5% | -$3.08K | 0.02% | 117 |
|
|
2020
Q3 | $57.3K | Sell |
1,645
-211
| -11% | -$7.4K | 0.02% | 112 |
|
|
2020
Q2 | $57.6K | Hold |
1,856
| – | – | 0.02% | 105 |
|
|
2020
Q1 | $57.5K | Sell |
1,856
-389
| -17% | -$13.3K | 0.02% | 97 |
|
|
2019
Q4 | $83.5K | Hold |
2,245
| – | – | 0.03% | 103 |
|
|
2019
Q3 | $76.5K | Buy |
+2,245
| New | +$81.6K | 0.03% | 104 |
|
|
2019
Q2 | – | Sell |
-1,856
| Closed | -$74.8K | – | 1209 |
|
|
2019
Q1 | $74.8K | Hold |
1,856
| – | – | 0.03% | 94 |
|
|
2018
Q4 | $76.9K | Hold |
1,856
| – | – | 0.03% | 103 |
|
|
2018
Q3 | $77.6K | Hold |
1,856
| – | – | 0.03% | 112 |
|
|
2018
Q2 | $63.9K | Hold |
1,856
| – | – | 0.02% | 113 |
|
|
2018
Q1 | $62.5K | Buy |
1,856
+459
| +33% | +$15.8K | 0.02% | 106 |
|
|
2017
Q4 | $48K | Sell |
1,397
-146
| -9% | -$4.98K | 0.02% | 130 |
|
|
2017
Q3 | $52.3K | Sell |
1,543
-1,054
| -41% | -$33.9K | 0.02% | 123 |
|
|
2017
Q2 | $82.8K | Hold |
2,597
| – | – | 0.04% | 99 |
|
|
2017
Q1 | $84.3K | Sell |
2,597
-141
| -5% | -$4.45K | 0.04% | 76 |
|
|
2016
Q4 | $84.4K | Buy |
2,738
+1,054
| +63% | +$32.2K | 0.04% | 72 |
|
|
2016
Q3 | $54.1K | Hold |
1,684
| – | – | 0.03% | 84 |
|
|
2016
Q2 | $56.3K | Hold |
1,684
| – | – | 0.03% | 76 |
|
|
2016
Q1 | $47.4K | Hold |
1,684
| – | – | 0.03% | 95 |
|
|
2015
Q4 | $51.6K | Hold |
1,684
| – | – | 0.03% | 84 |
|
|
2015
Q3 | $50.2K | Hold |
1,684
| – | – | 0.03% | 86 |
|
|
2015
Q2 | $53.6K | Hold |
1,684
| – | – | 0.03% | 85 |
|
|
2015
Q1 | $55.6K | Buy |
1,684
+146
| +9% | +$4.64K | 0.03% | 73 |
|
|
2014
Q4 | $45.4K | Buy |
1,538
+106
| +7% | +$3.04K | 0.03% | 82 |
|
|
2014
Q3 | $40.2K | Buy |
1,432
+246
| +21% | +$6.9K | 0.03% | 88 |
|
|
2014
Q2 | $33.4K | Hold |
1,186
| – | – | 0.03% | 93 |
|
|
2014
Q1 | $36.1K | Sell |
1,186
-352
| -23% | -$10.5K | 0.03% | 91 |
|
|
2013
Q4 | $45.4K | Buy |
+1,538
| New | +$44.8K | 0.03% | 82 |
|
Other funds holding PFE
AIM
CWP
DADC
RAFFA WEALTH MANAGEMENT, LLC's PFE Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC reduced its Pfizer (PFE) stake by 8.2% in Q2 2026, selling an estimated $1.57K and leaving 674 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #329.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $152K in Q1 2023. 1,008 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 674 shares of Pfizer worth $16.2K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC sold 60 Pfizer shares in Q2 2026, an estimated $1.57K.
- Pfizer made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #329 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Pfizer position peaked at $152K in Q1 2023.
- 1,008 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.